- Article
The BRAF P.V600E Mutation Status of Melanoma Lung Metastases Cannot Be Discriminated on Computed Tomography by LIDC Criteria nor Radiomics Using Machine Learning
- Lindsay Angus,
- Martijn P. A. Starmans,
- Ana Rajicic,
- Arlette E. Odink,
- Mathilde Jalving,
- Wiro J. Niessen,
- Jacob J. Visser,
- Stefan Sleijfer,
- Stefan Klein and
- Astrid A. M. van der Veldt
Patients with BRAF mutated (BRAF-mt) metastatic melanoma benefit significantly from treatment with BRAF inhibitors. Currently, the BRAF status is determined on archival tumor tissue or on fresh tumor tissue from an invasive biopsy. The aim of this st...